Sakar Healthcare Limited (SAKAR.NS)
INR 310.45
(-0.34%)
INR 310.45
(-0.34%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 793.51 Million INR | -28.67% |
| 2022 | 1.11 Billion INR | 19.8% |
| 2021 | 928.61 Million INR | 118.0% |
| 2020 | 425.97 Million INR | 155.11% |
| 2019 | 166.97 Million INR | 42.06% |
| 2018 | 117.53 Million INR | -19.2% |
| 2017 | 145.45 Million INR | -40.55% |
| 2016 | 244.66 Million INR | 10.62% |
| 2015 | 221.16 Million INR | -17.72% |
| 2014 | 268.8 Million INR | 2.07% |
| 2013 | 263.36 Million INR | -9.23% |
| 2012 | 290.14 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 838.73 Million INR | 0.0% |
| 2023 FY | 793.51 Million INR | -28.67% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 793.51 Million INR | 0.0% |
| 2023 Q2 | 682.29 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q2 | 1 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 1.11 Billion INR | 19.8% |
| 2022 Q4 | 1.11 Billion INR | 0.0% |
| 2021 FY | 928.61 Million INR | 118.0% |
| 2021 Q4 | 928.61 Million INR | 0.0% |
| 2021 Q2 | 629.9 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 425.97 Million INR | 155.11% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 425.97 Million INR | 0.0% |
| 2020 Q2 | 344.13 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q4 | 166.97 Million INR | 0.0% |
| 2019 FY | 166.97 Million INR | 42.06% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 118.03 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 113.29 Million INR | 0.0% |
| 2018 Q4 | 117.53 Million INR | 0.0% |
| 2018 FY | 117.53 Million INR | -19.2% |
| 2017 FY | 145.45 Million INR | -40.55% |
| 2017 Q4 | 145.45 Million INR | 0.0% |
| 2017 Q2 | 233.18 Million INR | 0.0% |
| 2016 Q4 | 212.27 Million INR | 0.0% |
| 2016 FY | 244.66 Million INR | 10.62% |
| 2015 Q1 | 260.81 Million INR | -2.97% |
| 2015 Q4 | 221.16 Million INR | 0.0% |
| 2015 Q2 | 260.81 Million INR | 0.0% |
| 2015 FY | 221.16 Million INR | -17.72% |
| 2015 Q3 | 221.16 Million INR | -15.2% |
| 2014 FY | 268.8 Million INR | 2.07% |
| 2014 Q4 | 268.8 Million INR | 0.0% |
| 2013 FY | 263.36 Million INR | -9.23% |
| 2012 FY | 290.14 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 1.43 Billion INR | 44.529% |
| Ind-Swift Limited | 10.13 Billion INR | 92.174% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 76.158% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 98.806% |
| Innova Captab Limited | 2.45 Billion INR | 67.625% |
| Divi's Laboratories Limited | 30 Million INR | -2545.053% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -1625.71% |
| Morepen Laboratories Limited | 289.99 Million INR | -173.634% |
| Mankind Pharma Limited | 2.07 Billion INR | 61.698% |
| Sequent Scientific Limited | 4.87 Billion INR | 83.729% |
| Wanbury Limited | 1.16 Billion INR | 31.878% |
| Laurus Labs Limited | 25.77 Billion INR | 96.921% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 87.514% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -362.746% |
| Alembic Limited | 91.5 Million INR | -767.231% |
| Hikal Limited | 8.17 Billion INR | 90.294% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 84.537% |
| Neuland Laboratories Limited | 953.89 Million INR | 16.813% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 78.989% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 93.554% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -142.221% |
| Themis Medicare Limited | 957.92 Million INR | 17.163% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 90.133% |
| Lupin Limited | 29.21 Billion INR | 97.284% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -4491.309% |
| Wockhardt Limited | 23.56 Billion INR | 96.632% |
| Vaishali Pharma Limited | 134.91 Million INR | -488.147% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 72.182% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -787.503% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 97.834% |
| FDC Limited | 205.18 Million INR | -286.732% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 96.036% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -150.744% |
| Eris Lifesciences Limited | 27.81 Billion INR | 97.147% |
| Venus Remedies Limited | 413.3 Million INR | -91.995% |
| ZIM Laboratories Limited | 1.08 Billion INR | 27.083% |
| Bliss GVS Pharma Limited | 998.4 Million INR | 20.521% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -3928.0% |
| Shilpa Medicare Limited | 9.37 Billion INR | 91.535% |
| Albert David Limited | 33.24 Million INR | -2287.089% |
| Ajanta Pharma Limited | 352.8 Million INR | -124.92% |
| Hester Biosciences Limited | 2.44 Billion INR | 67.529% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -22.086% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 92.155% |
| Gufic Biosciences Limited | 3.32 Billion INR | 76.165% |
| Windlas Biotech Limited | 36.41 Million INR | -2079.39% |
| Procter & Gamble Health Limited | 95.6 Million INR | -730.038% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -153.097% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | 19.434% |
| Granules India Limited | 13.15 Billion INR | 93.966% |
| Aarti Drugs Limited | 5.64 Billion INR | 85.937% |
| Bal Pharma Limited | 1.39 Billion INR | 43.178% |
| Alkem Laboratories Limited | 14.18 Billion INR | 94.406% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 97.576% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -7338.283% |
| Medicamen Biotech Limited | 308.17 Million INR | -157.491% |
| Unichem Laboratories Limited | 2.47 Billion INR | 67.941% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -225.354% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -17979.654% |
| Valiant Laboratories Limited | 767.08 Million INR | -3.446% |
| Orchid Pharma Limited | 1.35 Billion INR | 41.3% |
| Medico Remedies Limited | 80.5 Million INR | -885.685% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -377.4% |
| Ipca Laboratories Limited | 14.38 Billion INR | 94.483% |
| Brooks Laboratories Limited | 56.41 Million INR | -1306.469% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -9.471% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.852% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 98.027% |
| NATCO Pharma Limited | 3.71 Billion INR | 78.623% |
| Suven Life Sciences Limited | 7.09 Million INR | -11081.006% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 58.976% |
| Strides Pharma Science Limited | 25.16 Billion INR | 96.847% |
| Indoco Remedies Limited | 6.71 Billion INR | 88.191% |
| Alpa Laboratories Limited | 52.46 Million INR | -1412.467% |
| Lasa Supergenerics Limited | 220.76 Million INR | -259.444% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -29.765% |